Lord, Abbett & Co
ESPR

Lord, Abbett & Co’s Esperion Therapeutics ESPR Stock Holding History

Lord, Abbett & Co’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-467,466
Closed -$2.91M – 581
2022
Q4 		$2.91M Buy
+467,466
New +$3.34M 0.01% 531
2018
Q2 		– Sell
-91,887
Closed -$6.65M – 860
2018
Q1 		$6.65M Sell
91,887
-138,565
-60% -$10.2M 0.02% 688
2017
Q4 		$15.2M Sell
230,452
-5,437
-2% -$293K 0.04% 537
2017
Q3 		$11.8M Buy
235,889
+96,912
+70% +$4.67M 0.03% 603
2017
Q2 		$6.43M Buy
+138,977
New +$5.11M 0.02% 730

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return